Onconeural antibodies in patients with neurological symptoms: detection and clinical significance
Authors:
- 28 June 2011
- journal article
- review article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 124 (s191) , 83-88
Abstract
Onconeural antibodies are strongly associated with cancer and paraneoplastic neurological syndromes (PNS). Most of these antibodies are well-characterized (antibodies against Hu, Yo, Ri, CRMP5, amphiphysin, Ma2 and Tr) and are in common use for the diagnosis of definite PNS. Literature on detection and clinical significance of onconeural antibodies were identified by using relevant search terms in PubMed and reviewed. The onconeural antibodies are directed against intracellular antigens and their pathogenic role is still largely unknown. They are highly specific markers of paraneoplastic aetiology in patients with neurological symptoms. Detection of an onconeural antibody in a patient with neurological symptoms should lead to prompt investigation for cancer. However, absence of detectable onconeural antibodies does not exclude the PNS diagnosis. In particular, failure to detect antibodies in patients without classical PNS symptoms may result in less vigorous cancer screening and diagnostic delay. Neuronal antibodies that are directed to synaptic proteins or proteins of the cell membrane are also associated with neurological symptoms, and probably have pathogenic effects. The association between these antibodies and cancer is less robust, and they are usually not included among the onconeural antibodies.Keywords
This publication has 31 references indexed in Scilit:
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Update on Paraneoplastic and Autoimmune Disorders of the Central Nervous SystemSeminars in Neurology, 2010
- Antibodies and neuronal autoimmune disorders of the CNSJournal of Neurology, 2009
- SOX1 antibodies are markers of paraneoplastic Lambert–Eaton myasthenic syndromeNeurology, 2008
- Recommended diagnostic criteria for paraneoplastic neurological syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitisBrain, 2004
- Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate ReceptorNew England Journal of Medicine, 2000
- Neuronal antinuclear antibody in sensory neuronopathy from lung cancerNeurology, 1985
- Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinomaAnnals of Neurology, 1983
- PRIMARY SENSORY NEUROPATHY WITH MUSCULAR CHANGES ASSOCIATED WITH CARCINOMAJournal of Neurology, Neurosurgery & Psychiatry, 1948